neobookRx
DrugsLevel 4 LocalisationS0/S3CAP · TABEML

Silymarin

LipotropicHepatoprotective agent

Indications

Registered South African indications:

  • Aid in the treatment of alcohol-induced liver disease

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Pregnancy
  • Breastfeeding

Cautions

  • Renal impairment
  • Hepatic impairment
  • Elderly
  • Porphyria
  • History of Stevens-Johnson Syndrome
  • History of drug-induced phototoxicity

Adult dosage

Forms avail. in SA and covered in this monograph: tab, cap

Alcohol-induced liver disease 

  • Oral (tab): Initial: 140mg, 8hrly; Maintenance: 70mg, 8hrly
  • Oral (cap): 140mg, 8hrly; Max: 420mg/24 hrs

Silymarin is not suitable for treating cases of acute poisoning


The duration of treatment to be decided by the prescribing doctor


The capsules are to be swallowed whole and unchewed with an appropriate amount of liquid

Paediatric dosage

Not indicated for use in children below 12 years

Special populations

Pregnancy 

  • Contraindicated
  • There are no adequate data from the use of silymarin in pregnant women. Therefore, in these circumstances silymarin should not be administered

Breastfeeding

  • Contraindicated
  • There are no adequate data from the use of silymarin in breastfeeding women. Therefore, in these circumstances silymarin should not be administered

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Respiratory Disorders

  • Dyspnoea

Gastrointestinal Disorders

  • Diarrhoea

Skin and Subcutaneous Tissue Disorders

  • Rash
  • Urticaria

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity reactions

Interactions

Due to the herbal nature of this product, limited data related to drug interactions are available

  • UGT1A1 inhibitor
  • UGT1A1 substrates
  • UGT1A1 inducers
  • Lipid-lowering agents
  • HMG CoA reductase inhibitors
  • Nonsteroidal anti-inflammatory drug
  • Antiepileptic agents
  • Immunosuppressants
  • Mycophenolate mofetil
  • Oestrogens
  • Estradiol
  • Dolutegravir
  • Zidovudine
  • Rifampicin
  • Probenecid
  • Irinotecan
  • Furosemide
  • Losartan
  • Raloxifene
  • Levothyroxine

Monitoring

None routine

Prescribing points

  • The treatment with silymarin does not serve as a substitute for the abstention from the cause of liver damage (e.g. alcohol)
  • If icterus (light to dark yellow tinge of the skin, yellow discolouration of the white of the eye) occurs, the doctor is to be consulted

Mechanism of action

Silymarin (also known as silybin or silibinin) is standardised herbal extract of milk thistle seeds. Silymarin has a membrane-stabilising effect and an RNA-synthesis stimulating effect on hepatocytes.

Silymarin has free radical capturing powers, silymarin possesses antiperoxidative activity. The pathophysiological process of lipid peroxidation which is responsible for the destruction of cell membranes is interrupted or reduced. Furthermore, in liver cells, which have already sustained damage, silymarin stimulates protein synthesis and normalises phospholipid metabolism.

The enhancement of protein synthesis by silymarin is due to its stimulation of RNA polymerase I, an enzyme which is located in the nucleus. This leads to increased formation of ribosomal RNA and structure and function proteins (enzymes) are therefore synthesised in greater amounts.

Dosage forms

  • Capsule
  • Tablet

Formulation

Tablet 70mg

  • Legalon (Xixia Pharmaceuticals) originator

Capsule 140mg

  • Legalon Forte (Xixia Pharmaceuticals) originator

References

1. SAMF_12th Edition_Page 55 2. PI: Legalon 70, Takeda (Pty) Ltd. Date of publication of PI: Oct 1990. Updated 12 May 2020 [https://drive.google.com/drive/folders/10-3Cs6y9R6u_aQpHFbsvEA38zwIpUPgt] 3. Medicine Price Registry - 11 March 2020. Updated 12 May 2020 [https://docs.google.com/spreadsheets/d/18hXNriN78NcpWFDi-HglXSg5lOu_OX4e/edit#gid=1214068546] 4. PI: Legalon® Forte capsules, Takeda (Pty) Ltd. Date of publication of PI: 2 Oct 2014. Updated 12 May 2020 [https://drive.google.com/drive/folders/1roBB4DVhalP9NgrAYUth2aMzzlKLsTg4] 5. Clinical Pharmacologist - Dr. M Irhuma. Feedback regarding dosing queries [https://trello.com/c/JtweUfth/346-urgent-silymarin-legalon-legalon-forte-update-and-query-for-medicine-interactions 6. Voinovich D, et al. (2009). Journal of Pharmaceutical Sciences. 98 (11): 4119–29 7. Schull PD. NURSE’S DRUG Handbook (©McGraw-Hill) - Seventh edition. McGraw-Hill Education, LLC 8. The DrugBank database (version 5.1.6, released 2020-04-22) 9. NAPOS : Porphyria information: silymarin. Updated 13 May 2020 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=A05BA03] 10. SAID: Drugs in sport status: silymarin. Updated 13 May 2020 [http://www.drugfreesport.org.za/online-medication-check/legalon] **No SPC available

Brands & products

4 products · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days old

tabletGeneric· 2 products

from R3.07/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Legalon 7070 mg100S0R306.55R3.07R109.54785849017
Legalon 7070 mg40S0R151.53R3.79R64.31785849009

capsuleGeneric· 2 products

from R6.03/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Legalon ® Forte 140 mg100S0R603.02R6.03R173.183000442001
Legalon ® Forte 140 mg30S0R212.65R7.09R83.713000442002
Trade names (2)
  • Legalon
  • Legalon Forte

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 9 known drugs

Check against other drugs →
NeoHealth® ID 14730 · updated 11/10/2022